TV-1106 Phase 3 trial aimed to compare weekly dosing against daily rhGH for safety in GHD adults
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
Abstract
A terminated Phase 3 trial aimed to evaluate the safety and tolerability of weekly TV-1106 versus daily rhGH in adults with GHD.